{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T23:21:52Z","timestamp":1777764112674,"version":"3.51.4"},"reference-count":77,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA1301200"],"award-info":[{"award-number":["2021YFA1301200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373963"],"award-info":[{"award-number":["82373963"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474013"],"award-info":[{"award-number":["82474013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.dmd.2025.100116","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T11:43:13Z","timestamp":1751024593000},"page":"100116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Age-dependent pharmacokinetics of nifedipine in spontaneous hypertensive rats are associated with changes in gut microbiota and hepatic CYP3A1 expression"],"prefix":"10.1016","volume":"53","author":[{"given":"Yalan","family":"Xiong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fugang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honghao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10053","key":"10.1016\/j.dmd.2025.100116_bib1","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(16)31679-8","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.dmd.2025.100116_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrneph.2017.189","article-title":"Sex-specific differences in hypertension and associated cardiovascular disease","volume":"14","author":"Colafella","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"10.1016\/j.dmd.2025.100116_bib3","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1161\/HYPERTENSIONAHA.122.18459","article-title":"Isolated diastolic hypertension and risk of cardiovascular disease: controversies in hypertension\u2014pro side of the argument","volume":"79","author":"Yano","year":"2022","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.dmd.2025.100116_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries","volume":"134","author":"Mills","year":"2016","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.dmd.2025.100116_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/heartjnl-2018-313599","article-title":"Global prevalence of resistant hypertension: a meta-analysis of data from 3.2 million patients","volume":"105","author":"Noubiap","year":"2019","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.dmd.2025.100116_bib6","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2013.184182","article-title":"Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries","volume":"310","author":"Chow","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.dmd.2025.100116_bib7","article-title":"Prevalence, awareness, treatment, and control of hypertension in China, 2004-18: findings from six rounds of a national survey","volume":"380","author":"Zhang","year":"2023","journal-title":"BMJ"},{"issue":"Pt B","key":"10.1016\/j.dmd.2025.100116_bib8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.phrs.2017.09.011","article-title":"Combination drug treatment in hypertension","volume":"125","author":"Tsioufis","year":"2017","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.dmd.2025.100116_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00002512-200522040-00003","article-title":"Hypertension in the elderly: a Japanese perspective","volume":"22","author":"Ogihara","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.dmd.2025.100116_bib10","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2147\/PPA.S243665","article-title":"Analysis of adherence to antihypertensive drugs in chinese patients with hypertension: a retrospective analysis using the China Health Insurance Association Database","volume":"14","author":"Cui","year":"2020","journal-title":"Patient Prefer Adherence"},{"issue":"21","key":"10.1016\/j.dmd.2025.100116_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9149(90)91260-D","article-title":"In vitro models of anti-atherosclerotic effects of cardiovascular drugs","volume":"66","author":"Orekhov","year":"1990","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100116_bib12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1161\/01.CIR.83.2.460","article-title":"Nifedipine reduces the incidence of myocardial infarction and transient ischemia in patients undergoing coronary bypass grafting","volume":"83","author":"Seitelberger","year":"1991","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.dmd.2025.100116_bib13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41401-022-00948-w","article-title":"Low-dose nifedipine rescues impaired endothelial progenitor cell-mediated angiogenesis in diabetic mice","volume":"44","author":"Peng","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.dmd.2025.100116_bib14","first-page":"406","article-title":"The human intestinal microbiome at extreme ages of life. Dietary intervention as a way to counteract alterations","volume":"21","author":"Salazar","year":"2014","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.dmd.2025.100116_bib15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13073-016-0303-2","article-title":"Impact of the gut microbiota on inflammation, obesity, and metabolic disease","volume":"8","author":"Boulang\u00e9","year":"2016","journal-title":"Genome Med"},{"issue":"2","key":"10.1016\/j.dmd.2025.100116_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1152\/physiolgenomics.00081.2016","article-title":"Alterations in the gut microbiota can elicit hypertension in rats","volume":"49","author":"Adnan","year":"2017","journal-title":"Physiol Genomics"},{"issue":"7682","key":"10.1016\/j.dmd.2025.100116_bib17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nature24628","article-title":"Salt-responsive gut commensal modulates TH17 axis and disease","volume":"551","author":"Wilck","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.dmd.2025.100116_bib18","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","article-title":"Gut dysbiosis is linked to hypertension","volume":"65","author":"Yang","year":"2015","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.dmd.2025.100116_bib19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/CS20180087","article-title":"Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure","volume":"132","author":"Kim","year":"2018","journal-title":"Clin Sci (Lond)"},{"issue":"5","key":"10.1016\/j.dmd.2025.100116_bib20","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/HYPERTENSIONAHA.118.12109","article-title":"Gut microbiota composition and blood pressure","volume":"73","author":"Sun","year":"2019","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.dmd.2025.100116_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00248-022-02081-x","article-title":"Human gut microbiota and drug metabolism","volume":"86","author":"Pant","year":"2023","journal-title":"Microb Ecol"},{"issue":"7285","key":"10.1016\/j.dmd.2025.100116_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"issue":"6344","key":"10.1016\/j.dmd.2025.100116_bib23","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1126\/science.aag2770","article-title":"Chemical transformation of xenobiotics by the human gut microbiota","volume":"356","author":"Koppel","year":"2017","journal-title":"Science"},{"issue":"7762","key":"10.1016\/j.dmd.2025.100116_bib24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","article-title":"Mapping human microbiome drug metabolism by gut bacteria and their genes","volume":"570","author":"Zimmermann","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.dmd.2025.100116_bib25","doi-asserted-by":"crossref","first-page":"14184","DOI":"10.1038\/s41598-018-32366-6","article-title":"Commensal microbiota induces colonic barrier structure and functions that contribute to homeostasis","volume":"8","author":"Hayes","year":"2018","journal-title":"Sci Rep"},{"issue":"22","key":"10.1016\/j.dmd.2025.100116_bib26","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity","volume":"110","author":"Everard","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.dmd.2025.100116_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.bmt.1703815","article-title":"Alteration of pharmacokinetics of cyclophosphamide and suppression of the cytochrome p450 genes by ciprofloxacin","volume":"31","author":"Xie","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.dmd.2025.100116_bib28","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1124\/dmd.115.063545","article-title":"RNA-Seq quantification of hepatic drug processing genes in germ-free mice","volume":"43","author":"Selwyn","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.dmd.2025.100116_bib29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2133\/dmpk.22.96","article-title":"Effect of Lactobacillus casei on the absorption of nifedipine from rat small intestine","volume":"22","author":"Kato","year":"2007","journal-title":"Drug Metab Pharmacokinet"},{"issue":"5","key":"10.1016\/j.dmd.2025.100116_bib30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","article-title":"Pleiotropic roles of bile acids in metabolism","volume":"17","author":"de Aguiar Vallim","year":"2013","journal-title":"Cell Metab"},{"issue":"3-5","key":"10.1016\/j.dmd.2025.100116_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jsbmb.2011.06.012","article-title":"FXR and PXR: potential therapeutic targets in cholestasis","volume":"130","author":"Jonker","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100116_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2013.151","article-title":"Bile acid receptors as targets for drug development","volume":"11","author":"Schaap","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100116_bib33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.xphs.2020.09.013","article-title":"Pregnancy-related hormones increase nifedipine metabolism in human hepatocytes by inducing CYP3A4 expression","volume":"110","author":"Khatri","year":"2021","journal-title":"J Pharm Sci"},{"issue":"Suppl 4","key":"10.1016\/j.dmd.2025.100116_bib34","doi-asserted-by":"crossref","first-page":"S427","DOI":"10.33549\/physiolres.933512","article-title":"Bile acids, nuclear receptors and cytochrome P450","volume":"65","author":"Ju\u0159ica","year":"2016","journal-title":"Physiol Res"},{"issue":"6","key":"10.1016\/j.dmd.2025.100116_bib35","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1517\/17425255.2.6.847","article-title":"Pregnane X receptor and natural products: beyond drug-drug interactions","volume":"2","author":"Staudinger","year":"2006","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100116_bib36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40168-016-0222-x","article-title":"Gut microbiota dysbiosis contributes to the development of hypertension","volume":"5","author":"Li","year":"2017","journal-title":"Microbiome"},{"issue":"8","key":"10.1016\/j.dmd.2025.100116_bib37","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1161\/HYPERTENSIONAHA.121.18711","article-title":"Identification of a gut commensal that compromises the blood pressure-lowering effect of ester angiotensin-converting enzyme inhibitors","volume":"79","author":"Yang","year":"2022","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.dmd.2025.100116_bib38","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1161\/HYPERTENSIONAHA.122.19826","article-title":"Resistance to antihypertensive drugs: is gut microbiota the missing link?","volume":"79","author":"Kyoung","year":"2022","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.dmd.2025.100116_bib39","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.3390\/pharmaceutics15082085","article-title":"Effect of gut microbiota on the pharmacokinetics of nifedipine in spontaneously hypertensive rats","volume":"15","author":"Zhou","year":"2023","journal-title":"Pharmaceutics"},{"issue":"20","key":"10.1016\/j.dmd.2025.100116_bib40","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1128\/AEM.01071-12","article-title":"Selection for Cu-tolerant bacterial communities with altered composition, but unaltered richness, via long-term Cu exposure","volume":"78","author":"Berg","year":"2012","journal-title":"Appl Environ Microbiol"},{"issue":"8","key":"10.1016\/j.dmd.2025.100116_bib41","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/biom9080298","article-title":"The anticancer agent elesclomol has direct effects on mitochondrial bioenergetic function in isolated mammalian mitochondria","volume":"9","author":"Modica-Napolitano","year":"2019","journal-title":"Biomolecules"},{"issue":"14","key":"10.1016\/j.dmd.2025.100116_bib42","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1021\/acs.analchem.6b00573","article-title":"Key role for the 12-hydroxy group in the negative ion fragmentation of unconjugated C24 bile acids","volume":"88","author":"Lan","year":"2016","journal-title":"Anal Chem"},{"issue":"8","key":"10.1016\/j.dmd.2025.100116_bib43","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/ijc.30219","article-title":"Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis","volume":"139","author":"Xie","year":"2016","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.dmd.2025.100116_bib44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2133\/dmpk.19.103","article-title":"Differences in transactivation between rat CYP3A1 and human CYP3A4 genes by human pregnane X receptor","volume":"19","author":"Takada","year":"2004","journal-title":"Drug Metab Pharmacokinet"},{"issue":"5","key":"10.1016\/j.dmd.2025.100116_bib45","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1124\/mol.119.117333","article-title":"CYP3A4 induction in the liver and intestine of pregnane X receptor\/CYP3A-humanized mice: approaches by mass spectrometry imaging and portal blood analysis","volume":"96","author":"Kobayashi","year":"2019","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.dmd.2025.100116_bib46","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1194\/jlr.M044420","article-title":"Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice","volume":"55","author":"Cheng","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.dmd.2025.100116_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106589","article-title":"Free fatty acids induce bile acids overproduction and oxidative damage of bovine hepatocytes via inhibiting FXR\/SHP signaling","volume":"244","author":"Fang","year":"2024","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100116_bib48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1590\/S0102-67202012000100011","article-title":"Rat's age versus human\u2019s age: what is the relationship?","volume":"25","author":"Andreollo","year":"2012","journal-title":"Arq Bras Cir Dig"},{"issue":"6","key":"10.1016\/j.dmd.2025.100116_bib49","first-page":"624","article-title":"The laboratory rat: relating its age with human\u2019s","volume":"4","author":"Sengupta","year":"2013","journal-title":"Int J Prev Med"},{"issue":"9","key":"10.1016\/j.dmd.2025.100116_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074150","article-title":"Age-related P-glycoprotein expression in the intestine and affecting the pharmacokinetics of orally administered enrofloxacin in broilers","volume":"8","author":"Guo","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.dmd.2025.100116_bib51","doi-asserted-by":"crossref","first-page":"8592","DOI":"10.1007\/s13318-020-00651-3","article-title":"The effect of verapamil, a P-gp inhibitor, on the pharmacokinetics, safety, and tolerability of omadacycline in healthy adults: a phase I, open-label, single-sequence study","volume":"46","author":"Hunt","year":"2021","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.dmd.2025.100116_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154385","article-title":"Glycosides from Buyang Huanwu Decoction inhibit atherosclerotic inflammation via JAK\/STAT signaling pathway","volume":"105","author":"Fu","year":"2022","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.dmd.2025.100116_bib53","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/j.2040-4603.2016.tb00717.x","article-title":"Functions of the gallbladder","volume":"6","author":"Housset","year":"2016","journal-title":"Compr Physiol"},{"key":"10.1016\/j.dmd.2025.100116_bib54","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jare.2021.10.004","article-title":"Gut microbiota and host Cyp450s co-contribute to pharmacokinetic variability in mice with non-alcoholic steatohepatitis: effects vary from drug to drug","volume":"39","author":"Guo","year":"2022","journal-title":"J Adv Res"},{"issue":"1 Suppl","key":"10.1016\/j.dmd.2025.100116_bib55","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100116_bib56","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/03602530902722679","article-title":"Pharmacokinetics and drug metabolism in the elderly","volume":"41","author":"Klotz","year":"2009","journal-title":"Drug Metab Rev"},{"issue":"12","key":"10.1016\/j.dmd.2025.100116_bib57","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00228-008-0553-z","article-title":"Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction","volume":"64","author":"Verbeeck","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100116_bib58","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clpt.2004.09.004","article-title":"Marked effect of liver and kidney function on the pharmacokinetics of selegiline","volume":"77","author":"Anttila","year":"2005","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.dmd.2025.100116_bib59","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/0009-9236(95)90225-2","article-title":"Pharmacokinetics of the novel antiestrogenic agent toremifene in subjects with altered liver and kidney function","volume":"57","author":"Anttila","year":"1995","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.dmd.2025.100116_bib60","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2165\/00003088-200746120-00002","article-title":"Antiarrhythmics: elimination and dosage considerations in hepatic impairment","volume":"46","author":"Klotz","year":"2007","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"10.1016\/j.dmd.2025.100116_bib61","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2215\/CJN.00340118","article-title":"Clinical pharmacokinetics in kidney disease","volume":"13","author":"Lea-Henry","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.dmd.2025.100116_bib62","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.3390\/biomedicines10112686","article-title":"The role of CYP3A in health and disease","volume":"10","author":"Klyushova","year":"2022","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.dmd.2025.100116_bib63","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.clpt.2004.07.001","article-title":"Cytochrome P450 3A expression and activity in the human small intestine","volume":"76","author":"Yang","year":"2004","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.dmd.2025.100116_bib64","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1124\/jpet.106.106013","article-title":"Intestinal and hepatic metabolic activity of five cytochrome P450 enzymes: impact on prediction of first-pass metabolism","volume":"318","author":"Galetin","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.dmd.2025.100116_bib65","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s10753-019-01085-z","article-title":"Paeoniflorin prevents intestinal barrier disruption and inhibits lipopolysaccharide (LPS)-induced inflammation in Caco-2 cell monolayers","volume":"42","author":"Wu","year":"2019","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.dmd.2025.100116_bib66","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41396-022-01333-5","article-title":"Genome-centric investigation of bile acid metabolizing microbiota of dairy cows and associated diet-induced functional implications","volume":"17","author":"Lin","year":"2023","journal-title":"ISME J"},{"issue":"22","key":"10.1016\/j.dmd.2025.100116_bib67","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.3390\/molecules27227830","article-title":"Bile acids: physiological activity and perspectives of using in clinical and laboratory diagnostics","volume":"27","author":"Shansky","year":"2022","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.dmd.2025.100116_bib68","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1194\/jlr.R054114","article-title":"Intestinal transport and metabolism of bile acids","volume":"56","author":"Dawson","year":"2015","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.dmd.2025.100116_bib69","doi-asserted-by":"crossref","first-page":"4289383","DOI":"10.1155\/2022\/4289383","article-title":"A review of bile acid metabolism and signaling in cognitive dysfunction-related diseases","volume":"2022","author":"Weng","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.dmd.2025.100116_bib70","doi-asserted-by":"crossref","first-page":"1011994","DOI":"10.3389\/fendo.2022.1011994","article-title":"Role of bile acids in overweight and obese children and adolescents","volume":"13","author":"Giannini","year":"2022","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100116_bib71","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00228-019-02825-8","article-title":"Effects of ursodeoxycholic acid on rilpivirine plasma trough concentrations: a case report","volume":"76","author":"Cattaneo","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.dmd.2025.100116_bib72","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1517\/17425255.2012.685237","article-title":"Role of CAR and PXR in xenobiotic sensing and metabolism","volume":"8","author":"Wang","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"5","key":"10.1016\/j.dmd.2025.100116_bib73","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1124\/dmd.121.000385","article-title":"Tertiary oxidation of deoxycholate is predictive of CYP3A activity in dogs","volume":"49","author":"Zeng","year":"2021","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100116_bib74","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.toxlet.2016.11.013","article-title":"Acetylated deoxycholic (DCA) and cholic (CA) acids are potent ligands of pregnane X (PXR) receptor","volume":"265","author":"Carazo","year":"2017","journal-title":"Toxicol Lett"},{"issue":"22","key":"10.1016\/j.dmd.2025.100116_bib75","doi-asserted-by":"crossref","first-page":"13967","DOI":"10.3390\/ijms232213967","article-title":"The farnesoid X receptor as a master regulator of hepatotoxicity","volume":"23","author":"Rausch","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.dmd.2025.100116_bib76","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/CIRCRESAHA.120.318155","article-title":"Restructuring the gut microbiota by intermittent fasting lowers blood pressure","volume":"128","author":"Shi","year":"2021","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.dmd.2025.100116_bib77","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/HJH.0000000000000773","article-title":"Effects of orally administered antibiotics on the bioavailability of amlodipine: gut microbiota-mediated drug interaction","volume":"34","author":"Yoo","year":"2016","journal-title":"J Hypertens"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:58:56Z","timestamp":1777474736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625091251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":77,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0090955625091251"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100116","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age-dependent pharmacokinetics of nifedipine in spontaneous hypertensive rats are associated with changes in gut microbiota and hepatic CYP3A1 expression","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100116"}}